Current > >Home >News
Warmly celebrate Yinfeng Gene Technology Co., Ltd. has discovered two more new human genes and obtained the certification.
Time: 2023-06-30
On June 30, 2023, Yinfeng Gene Technology Co., Ltd. successfully declared 2 cases of unreported human HLA gene sequences, which passed the recognition of the World Health Organization's HLA Nomenclature Committee, and was awarded the certificate of new gene authentication. Up to now, Yinfeng Gene has discovered a total of 20 cases of new human genes.
After a lot of systematic research and identification, the HLA team of Yinfeng Gene was the first to discover the 2 new gene sequences in the world, and submitted to the HLA Naming Committee of the World Health Organization through the IPD-IMGT/HLA website, and passed the certification of the HLA Naming Committee of the World Health Organization and was awarded the certificate of certification of new genes on June 30, 2023, and the 2 new genes were formally named C*03 These two new genes are officially named as C*03:639 and A*24:604, which is the first time that this new HLA allele is found in the world, showing the advanced technology research and development and gene interpretation strength of Yinfeng HLA team.
HLA (human leucocyte antigen), or human leucocyte antigen, is the expression product of the human major histocompatibility complex (MHC), which is the most complex polymorphic system known to the human body. It is closely related to rejection and recurrence rates after clinical hematopoietic stem cell and organ transplantation; it is also closely associated with the susceptibility to and occurrence of more than 200 diseases, such as AIDS (HIV), tumors, and autoimmune diseases; it has also been widely used in the fields of forensic DNA identification of physical evidence and human evolution.
The discovery of two new human gene sequences expands the database of human genetic typing and enriches the information of human genetics, which is of great academic value to the research of anthropology and genetics in China, and at the same time provides a more accurate basis for HLA typing in organ and hematopoietic stem cell transplants, and reduces the risk of genetic leakage and misdiagnosis.
Yinfeng Gene HLA Laboratory has accumulated more than 930,000 cases of HLA typing samples and 15,000 cases of rare type samples, and owns a full set of testing technologies and platforms such as SSP, SSO, SBT and NGS in the field of HLA typing, and has published 11 SCI papers, so its testing and research and development strength is at the international advanced level, and the relevant papers of this new gene will also be published in the international authoritative immunogenetic journal HLA".


Jinan Yinfeng Medical Laboratory is a wholly-owned subsidiary of Yinfeng Biological Group, which is one of the first batch of national demonstration centers for the application of genetic testing technology, a national high-tech enterprise, and the first laboratory in Shandong Province to pass the U.S. CAP accreditation by NGS, and to obtain ISO1518 certification issued by the China National Accreditation Service for Conformity Assessment (CNAS). "With more than 8000 square meters of professional genetic testing laboratories and relying on a strong technical platform and advanced equipment, the company carries out genomics research and genetic testing services, covering neonatal tertiary prevention system, tumor precision medicine, HLA typing, human susceptibility gene testing, whole-genome genetic testing, and other services, as well as the development of newborns. Yinfeng Genetics practices universal healthcare, always adheres to the dual-core drive of "innovation + service", and empowers health with diversified product innovation and accompanying diagnostic services. Yinfeng Genetics adheres to the international high-precision and ultimate service brand strategy, provides more comprehensive and systematic precision testing services for medical clinics and patients, and strives to become a leading medical and healthcare service provider. To provide more comprehensive, systematic and accurate testing services for medical clinics and patients, we are committed to becoming the most trustworthy partner of medical clinics and patients, Yinfeng Genetics - let gene technology serve mankind better.
  • Pre: Yinfeng Group was successfully selected as one of the top 100 private enterprises in Jinan and ranked fourth!
  • Next: The company's business team organized a grand celebration for the arrival of 2023.
  • Contact us

    Address: Yinfeng Building, No. 6 Liyang Street, Jinan City, Shandong Province
    Tel: 86-531-82724233
    WhatsApp/Phone: +86 19953153263
    Email:Anani@yfintltrade.com

    Connect social

    Top